Cite

HARVARD Citation

    Neukam, K. et al. (2015). Impact of IL28B Genotype on First-Week Response to Telaprevir-Based Therapy in HIV–HCV Coinfection. Antiviral therapy. 20 (4), pp. 407-413. [Online]. 
  
Back to record